Valuation BlossomHill Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 17:05:10 15/10/2026 BST			5-day change	1st Jan Change
15.00 ^USD	-1.74%		-9.66%	-

09-28	Blossomhill Therapeutics, Inc. Presents Preclinical Data on Novel Pan-KRAS Inhibitor, Bh-501284, At the AACR Conference on Pancreatic Cancer	CI
09-20	BlossomHill Therapeutics, Inc.(NasdaqGS:BLSM) added to S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	485	-	-
Change	-	-	-
Enterprise Value (EV)	485	485	485
Change	-	0%	0%
P/E	-2.78x	-4.62x	-4.37x
PBR	-	-	-
PEG	-0.8x	0.1x	-0.76x
Capitalization / Revenue	-	-	-
EV / Revenue	-	-	-
EV / EBITDA	-4.35x	-3.58x	-3.04x
EV / EBIT	-4.42x	-3.73x	-3x
EV / FCF	-5.27x	-4.29x	-5.08x
FCF Yield	-19%	-23.3%	-19.7%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-5.483	-3.302	-3.491
Distribution rate	-	-	-
Net sales ¹	-	-	-
EBITDA ¹	-111.5	-135.7	-159.4
EBIT ¹	-109.7	-130.1	-161.5
Net income ¹	-104.9	-121	-152.7
Net Debt	-	-	-
Reference price ²	15.26	15.26	15.26
Nbr of stocks (in thousands)	31,785	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BLOSSOMHILL THERAPEUTICS, INC.	-2.78x	-	-	-	485M
WUXI APPTEC CO., LTD.	20.03x	7.14x	14.3x	1.48%	68.92B
ARGENX SE	27.94x	7.65x	24.01x	0.05%	51.9B
LONZA GROUP AG	34.21x	6.11x	18.26x	0.95%	48.73B
IQVIA HOLDINGS INC.	33.07x	3.27x	14.12x	-.--%	43.13B
REVOLUTION MEDICINES, INC.	-20.06x	203.22x	-21.36x	-.--%	41.48B
BEONE MEDICINES AG	46.56x	5.29x	29.06x	-.--%	39.96B
CELLTRION, INC.	26.85x	7.63x	19.75x	0.4%	30.6B
WUXI BIOLOGICS (CAYMAN) INC.	30.04x	6.38x	16.56x	-.--%	26.01B
BIONTECH SE	-13.53x	5x	-6.04x	-.--%	22.27B
Average	18.23x	27.97x	12.07x	0.32%	37.35B
Weighted average by Cap.	22.10x	28.09x	13.15x	0.44%